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ABSTRACT

ARTICLE HISTORY

Prostaglandin E2 (PGE2) is a key paracrine mediator of ovulation. Few speciﬁc PGE2-regulated gene
products have been identiﬁed, so we hypothesized that PGE2 may regulate the expression and/or
activity of a network of proteins to promote ovulation. To test this concept, Ingenuity Pathway
Analysis (IPA) was used to predict PGE2-regulated functionalities in the primate ovulatory follicle.
Cynomolgus macaques underwent ovarian stimulation. Follicular granulosa cells were obtained
before (0 h) or 36 h after an ovulatory dose of human chorionic gonadotropin (hCG), with
ovulation anticipated 37–40 h after hCG. Granulosa cells were obtained from additional monkeys
36 h after treatment with hCG and the PTGS2 inhibitor celecoxib, which signiﬁcantly reduced
hCG-stimulated follicular prostaglandin synthesis. Granulosa cell RNA expression was determined
by microarray and analyzed using IPA. No granulosa cell mRNAs were identiﬁed as being
signiﬁcantly up-regulated or down-regulated by hCG + celecoxib compared with hCG only.
However, IPA predicted that prostaglandin depletion signiﬁcantly regulated several functional
pathways. Cell cycle/cell proliferation was selected for further study because decreased
granulosa cell proliferation is known to be necessary for ovulation and formation of a fullyfunctional corpus luteum. Prospective in vivo and in vitro experiments conﬁrmed the prediction
that hCG-stimulated cessation of granulosa cell proliferation is mediated via PGE2. Our studies
indicate that PGE2 provides critical regulation of granulosa cell proliferation through
mechanisms that do not involve signiﬁcant regulation of mRNA levels of key cell cycle
regulators. Pathway analysis correctly predicted that PGE2 serves as a paracrine mediator of this
important transition in ovarian structure and function.
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Introduction
The midcycle surge of luteinizing hormone (LH) initiates
structural and functional changes within the ovulatory
follicle which culminate in release of the oocyte and formation of the corpus luteum (Duﬀy et al. 2019). Follicular
prostaglandins are low prior to the LH surge. The LH
surge initiates follicular synthesis of prostaglandins and,
in particular, prostaglandin E2 (PGE2) (Sirois 1994; Sirois
and Dore 1997; Mikuni et al. 1998; Duﬀy and Stouﬀer
2001). Locally-elevated PGE2 is a critical mediator of ovulatory changes including expansion of cumulus granulosa cells, angiogenesis, follicle rupture, and release of
an oocyte capable of fertilization (Duﬀy 2015; Trau
et al. 2015). Blockade of PGE2 synthesis or action
results in unruptured follicles with retained oocytes
(Hizaki et al. 1999; Tilley et al. 1999; Duﬀy and Stouﬀer
2002).
PGE2 plays a critical role in ovulation. Perhaps surprisingly, few PGE2-regulated gene products have been
CONTACT Diane M. Duﬀy

duﬀydm@evms.edu
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identiﬁed in the ovulatory follicle. Gene array analyses
focusing on gene expression regulated by the LH surge
(or hCG in experimental models) have identiﬁed numerous gonadotropin-regulated genes in ovarian cells and
tissues from rodents, domestic animals, monkeys, and
humans (Fan et al. 2009; Xu et al. 2011; Christenson
et al. 2013; Wissing et al. 2014). Since the LH surge
initiates synthesis of ovulatory prostaglandins, we
might expect that prostaglandin-regulated genes
should be a subset of all LH-regulated genes. A few prostaglandin-regulated genes have been identiﬁed in prospective studies of LH-regulated genes (Seachord et al.
2005; Li Q et al. 2006; Sayasith et al. 2008; Markosyan
and Duﬀy 2009). Additional prostaglandin-regulated
gene products have been identiﬁed after ovulatory dysfunctions were noted in mice lacking expression of the
key prostaglandin synthesis enzyme PTGS2 (Hizaki
et al. 1999; Tilley et al. 1999). However, the well-established failure of ovulation in the absence of

Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA 23501, USA

© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of the Korean Society of Integrative Biology
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.

DEVELOPMENTAL
BIOLOGY

Granulosa cell proliferation is inhibited by PGE2 in the primate ovulatory follicle

P. S. LUNDBERG ET AL.

Granulosa cells and whole ovaries were obtained from
adult female cynomolgus macaques (Macaca fascicularis)
aged 4–10 years, 3–4.5 kg, at Eastern Virginia Medical
School (EVMS). All animal protocols and experiments
were approved by the EVMS Animal Care and Use Committee and were conducted in accordance with the
National Institutes of Health Guide for the Care and
Use of Laboratory Animals. Animal husbandry and
sample collection were performed as previously
described (Seachord et al. 2005). Brieﬂy, blood samples
were obtained under ketamine chemical restraint by
femoral venipuncture, and serum was stored at –20°C.
Aseptic surgeries were performed in a dedicated surgical
suite under isoﬂurane anesthesia, and post-operative
pain was controlled with buprenorphine alone or in combination with ketoprofen.
A controlled ovarian stimulation model developed for
the collection of multiple oocytes for in vitro fertilization

Monkey ovarian cells and tissues

Materials and methods

prostaglandins cannot reasonably be explained by regulation of a such a small number of gene products.
The goal of this study was to use pathway analysis to
identify prostaglandin-regulated functionalities of granulosa cells. While changes in functionalities may be secondary to altered gene expression, functionalities may
also be linked to prostaglandin-dependent changes in
the function of existing proteins. Ex vivo gene expression
analysis was performed using granulosa cells obtained
from monkeys before and after an ovulatory gonadotropin stimulus; additional granulosa cells were obtained
after an ovulatory gonadotropin stimulus in combination
with the PTGS2 inhibitor celecoxib. Unbiased analysis
identiﬁed speciﬁc pathways that showed signiﬁcant predicted functional changes with PGE2 depletion. Followup studies demonstrated that PGE2 reduced cell cycle
progression by granulosa cells, an essential step in the
transition from preovulatory follicle to corpus luteum.
Our studies indicate that PGE2 provides critical regulation
of granulosa cell proliferation through mechanisms that
do not require a signiﬁcant change in the mRNA level of
any individual cell cycle regulator. The literature does
provide precedent for the concept that subtle changes
in many gene products results in measurable, functional
changes in cell function. Pathway analysis correctly predicted that PGE2 serves as a paracrine mediator of this
important transition in ovarian structure and function.
Overall, these studies demonstrate the utility of pathway
analysis to identify ovulatory pathways regulated by
PGE2 and other paracrine mediators of ovulation.
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was used to obtain monkey granulosa cells (Seachord
et al. 2005). Beginning within 3 days of initiation of menstruation, FSH (90 IU daily, Merck and Co., Inc., Kenilworth, NJ) was administered for 6–8 days, followed by
daily administration of 90 IU FSH plus 60 IU LH (Serono
Reproductive Biology Institute, Rockland, MA) for 2
days to stimulate the growth of multiple preovulatory
follicles. A GnRH antagonist (Antide,0.5 mg/kg body
weight; Serono) was also administered daily to prevent
an endogenous ovulatory LH surge. Adequate follicular
development was monitored by serum estradiol levels
and ultrasonography. Follicular aspiration was performed
during aseptic surgery before (0 h) or up to 36 h after
administration of 1000 IU r-hCG (EMD Serono). To
inhibit follicular prostaglandin production during the
ovulatory interval, additional animals were treated with
gonadotropins and Antide as described above; these
animals also received the PTGS2 inhibitor celecoxib (Celebrex, Pﬁzer, NY; 6.7 mg/kg body weight orally every
12 h) beginning with hCG administration until follicles
were aspirated 36 h later (Seachord et al. 2005). At aspiration, each follicle ≥4 mm in diameter was pierced with a
22-gauge needle, and the contents of all aspirated follicles were pooled. Ovulatory follicles in cynomolgus
macaques are typically 4–6 mm in diameter as assessed
by ultrasonography and conﬁrmed by direct measurement at surgery; ovulation is anticipated 37–40 h after
hCG in this species. Whole ovaries were also obtained
from monkeys experiencing ovarian stimulation as
described above. Ovaries were bisected, maintaining at
least two follicles greater than 4 mm in diameter on
each piece. Ovarian pieces were ﬁxed in 10% formalin
for paraﬃn sections.

Monkey granulosa cell RNA, Aﬀymetrix array, and
Ingenuity Pathway Analysis
Monkey granulosa cells and oocytes were pelleted from
the follicular aspirates by centrifugation at 250 X
g. Following oocyte removal, a granulosa cell-enriched
population of cells was obtained by Percoll gradient centrifugation (Seachord et al. 2005); viability was assessed
by trypan blue exclusion and averaged 85%. Granulosa
cells were stored at –80°C until RNA was isolated using
Trizol reagent. Total RNA from monkey granulosa cell
obtained at 0 h hCG, 36 h hCG, and 36 h hCG + celecoxib
were processed using the Aﬀymetrix GeneChip WT PLUS
Reagent Kit and hybridized to Gene Atlas Cynomolgus
Gene 1.1 ST Arrays Strips, and Robust Multichip
Average (RMA)-normalized (Irizarry et al. 2003). Gene
IDs from Macaca fascicularis (GCA_000364345.1 2013/
06/12 version) was used to verify transcripts reported
in this study. Gene Level expression data (p<0.05

threshold) was imported to Ingenuity Pathway Analysis
(IPA, Germantown, MD) software for analysis. Expression
ratios were generated, ratios of gene expression data
were overlaid on expressed genes in networks, and the
IPA Molecule Activity Predictor was used to color-code
upstream regulators.

Human granulosa cells
Granulosa cells were obtained from healthy women
undergoing ovarian stimulation for oocyte donation at
the Jones Institute for Reproductive Medicine at EVMS.
The Institutional Review Board at EVMS determined
that this use of discarded human granulosa cells does
not constitute human subjects research as deﬁned by
45 CFR 46.102(f). Follicular aspirates are routinely collected 34–36 h after administration of an ovulatory
dose of hCG. Granulosa cells were transferred to our laboratory after oocyte removal. A granulosa cell-enriched
population of cells was obtained by Percoll gradient centrifugation as described above for monkey granulosa
cells. Cells were cultured on ﬁbronectin-coated
chamber slides (Nalgene Nunc, Rochester, NY) in
DMEM/F12 media (Sigma) containing 10% fetal bovine
serum (Atlanta Biologicals), penicillin (100 U/ml), streptomycin (100 µg/ml), insulin (10 µg/ml), transferrin (10 µg/
ml), and selenium (10 ng/ml). Media were changed each
day for 7 days as has been shown to allow these granulosa cells to regain gonadotropin responsiveness comparable to granulosa cells obtained from large,
preovulatory follicles (Freimann et al. 2004; Al-Alem
et al. 2015). To initiate treatments, fresh media was supplemented with ﬁnal concentrations of hCG (20 IU/ml,
Sigma), the general cyclooxygenase inhibitor indomethacin (0.1 μM, Sigma), and/or PGE2 (0.1 μM,
Cayman). After 24 or 48 h in vitro, media was removed,
cells were ﬁxed in 10% formalin for 20 min, and slides
were stored in phosphate buﬀered saline at 4C until
used for immunodetection of Ki67.

Quantitative RT-PCR (qPCR)
Determination of granulosa cell levels of individual
mRNAs was conducted by qPCR using a Roche LightCycler (Roche Diagnostics, Indianapolis, IN). Total RNA was
obtained from granulosa cells using Trizol reagent,
treated with DNase and reverse transcribed as previously
described (Duﬀy, Dozier, et al. 2005). PCR was performed
using the FastStart DNA Master SYBR Green I kit (Roche)
following manufacturer’s instructions. Primers were
designed using Primer-Blast (NCBI; http://www.ncbi.
nlm.nih.gov/tools/primer-blast) based on available
human or monkey sequences and span an intron to

NM_001238

NM_031966.2
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ATCCGCAAAGACCTGT
GTCCGCTAGAAGCAT
ACCTGATGGAACTAACTATGT
GTGCTTTGTAAGTCCTTGAT
CAGCCCCATCATGCCGA
TCACACACCTCCATTAACCAA

Primer sequence (5′ –3′ )

Table 1. Primers for qPCR.
Target
ACTB
CCNB1

Up
Down
Up
Down
Up
Down

Data were assessed for heterogeneity of variance using
Bartlett’s test; data were log-transformed when Bartlett’s
test yielded a signiﬁcance of < 0.05. Data were then
assessed by ANOVA. ANOVA with one repeated
measure was used for cell culture experiments to
reﬂect repeated use of cells from an individual woman
in all treatments in vitro. For ANOVA, post hoc analyses
were performed using Duncan’s multiple range test. Statistical analyses were performed using StatPak v4.12

Statistical analysis

Immunodetection of Ki67
Deparaﬃnized monkey ovarian sections and human granulosa cells on chamber slides were used for immunodetection of the proliferation antigen Ki67 essentially as
previously described (Duﬀy, Seachord, et al. 2005). Brieﬂy,
a mouse monoclonal antibody against human Ki67
(Dako, Glostrup, Denmark) was used at a 1:100 dilution
(ﬁnal concentration 46 µg/L); immunodetection was
achieved using a biotinylated anti-mouse IgG ABC kit
(Vector Laboratories, Burlingame, CA) and visualized with
DAB (brown stain, Vector). In some experiments, the
primary antibody was omitted as a negative control. All
slides were counterstained with hematoxylin. To quantify
Ki67, each tissue section or chamber was imaged 4 times
in a predetermined standard pattern using an Olympus
BX41 microscope ﬁtted with a DP70 digital camera and
associated software (Melville, NY). For each image, nuclei
with brown stain (Ki67+) and nuclei lacking brown stain
(blue; Ki67-) were counted. A minimum of 150 nuclei
were counted on each image. Replicates for each tissue
section or chamber were averaged.

prevent undetected ampliﬁcation of genomic DNA
(Table 1). PCR products were sequenced (Genewiz,
South Plainﬁeld, NJ) to conﬁrm amplicon identity. At
least 5 log dilutions of the sequenced PCR product
were included in each assay and used to generate a standard curve. For each sample, the content of mRNA of
interest and ACTB mRNA was determined in independent
assays. No ampliﬁcation was observed when cDNA was
omitted. All data were expressed as the ratio of mRNA
of interest to ACTB mRNA for each sample.

CCNE1

®
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Gene Symbol
HIST1H2BL
APCDD1
PTGES
ADAMTS9
FCGR2A
DHRS9
ENPP1
OLFM4
CRYAB
RUNX2
MOCOS
PRLR
ANKRD22
EREG
NNMT
GPC4
SHC4
ABCA9
AP1S2
FSTL3
LGALS3
TNFAIP6
GXYLT2
FAM129B
HSD11B1
DIRAS3
MAP3K13
VNN1
SLC16A10
GFPT2
CACNA1E
COBLL1

Fold Change 36 h
hCG/0 h hCG
+1.547
−1.071
−1.038
−1.045
+1.396
+1.013
+1.001
−1.007
−1.109
−1.062
−1.076
+/−1.000*
+1.346
+1.050
−1.366
−1.100
−1.122
+1.019
−1.009
−1.055
−1.038
+1.201
−1.064
+1.091
+1.046
−1.094
−1.073
+1.226
−1.046
+1.002
−1.089
−1.180

Fold change 36 h
hCG+celecoxib/36 h hCG
histone cluster 1, H2bl
adenomatosis polyposis coli down-regulated 1
prostaglandin E synthase
ADAM metallopeptidase with thrombospondin type 1 motif, 9
Fc fragment of IgG, low aﬃnity IIa, receptor (CD32)
dehydrogenase/reductase (SCD family) member 9
ectonucleotide pyrophosphatase/phospodiesterase 1
olfactomedin 4
crystallin, alpha B
runt-related transcription factor 2
molybdenum cofactor sulfurase
prolactin receptor
ankyrin repeat domain 22 (transcription regulator)
epiregulin (growth factor)
nicotinamide N-methyltransferase
glypican 4
SHC (Src homology 2 domain containing) family, member 4
ATP-binding cassette, subfamily A (ABC1), member 9
adaptor-related protein complex 1, sigma 2 subunit
follicatin-like 3 (secreted glycoprotein)
lectin, galactoside-binding, soluble, 3
tumor necrosis factor, alpha-induced protein 6
glucoside xylosyltransferase 2
family with sequence similarity 129, member B
hydroxysteroid (11-beta) dehydrogenase 1
DIRAS family, GTP-binding RAS-like 3
mitogen-activated protein kinase kinase kinase 13
vanin 1
solute carrier family 16, member 10 (aromatic amino acid transporter)
glutamine-fructose-6-phosphate transaminase 2
calcium channel, voltage-dependent, R type, alpha 1E subunit
cordon-bleu WH2 repeat protein-like 1

Transcript Name

software (Northwest Analytical, Portland, OR). Data are
presented as mean + SEM, n = 3–5 monkeys or women
per treatment group or time point, and signiﬁcance
was assumed at p < 0.05.

Results
Identiﬁcation of gonadotropin- and
prostaglandin-sensitive gene products
In vivo exposure to an ovulatory gonadotropin stimulus
signiﬁcantly altered granulosa cell expression of 32 individual gene products. Granulosa cell mRNA levels
present after ovarian stimulation and 36 h of exposure
to hCG (36 h hCG) were compared with granulosa cell
mRNA levels present after ovarian stimulation in the
absence of hCG (0 h hCG). This comparison yielded 31
mRNAs signiﬁcantly increased by hCG treatment and 1
mRNA signiﬁcantly decreased by hCG treatment (Table 2).
The ovulatory gonadotropin surge initiates all ovulatory changes in the primate follicle. One key ovulatory
change is the initiation of prostaglandin synthesis, resulting in prostaglandin accumulation 24–36 h after hCG
administration, which we have previously reported
(Duﬀy, Dozier, et al. 2005). Note that follicle health is

IPA was used to generate the networks showing the
diﬀerential mRNA expression between treatment with

Identiﬁcation of pathways regulated by
gonadotropins and prostaglandins

dependent on continued gonadotropin stimulation. It is
not possible to determine the impact of PGE2 by simply
administering PGE2 in the absence of hCG. Instead, to
determine if a subset of all hCG-induced changes are
due to elevated follicular prostaglandins, additional
monkeys underwent ovarian stimulation followed by
36 h treatment with hCG and the PTGS2 inhibitor celecoxib, which has previously been shown to reduce hCGstimulated PGE2 (Seachord et al. 2005). Granulosa cell
expression of the histone cluster protein HIST1H2BL was
signiﬁcantly reduced by 36 h hCG treatment and somewhat, but not signiﬁcantly, increased with celecoxib treatment (Table 2). Prostaglandin-sensitive expression of a
single gene seemed insuﬃcient to explain the fact that
blockade of prostaglandin synthesis results in ovulation
failure. So, pathway analysis was performed to identify
candidate pathways which are regulated by hCG and
prostaglandins at levels other than gene transcription.

Genes with signiﬁcantly diﬀerent expression (±2-fold) for hCG-treated versus untreated granulosa cells (36 h/0 h; left) and the corresponding fold changes for 36 h
hCG+celecoxib-treated versus 36 h hGC-treated granulosa cells (36 h+celecoxib/36 h; right). *denotes no change.

−2.872
+3.260
+3.079
+2.776
+2.695
+2.591
+2.387
+2.381
+2.376
+2.370
+2.300
+2.296
+2.254
+2.185
+2.143
+2.135
+2.119
+2.087
+2.082
+2.072
+2.069
+2.067
+2.066
+2.065
+2.051
+2.048
+2.047
+2.044
+2.032
+2.018
+2.017
+2.001

Table 2. Gonadotropin and celecoxib regulated genes in monkey granulosa cells.
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Figure 1. Predicted granulosa cell gene networks regulated by hCG and celecoxib. Top up-regulated genes and down-regulated genes
(TG) and IPA-predicted change in upstream regulator (UR) gene activity when comparing 36 h hCG versus 0 h hCG (Panel A) and 36 h
hCG + celecoxib versus 36 h hCG (Panel B). Transcripts were included where TG with a change above absolute 2 (Table 1) and predicted
UR with an estimated signiﬁcance below p=0.05/Z-score > ABS(2.1) (Table 2). For clarity, p53 and Rb (purple) were not included in the
network build as they connected with most nodes in Panel A. Shown is the subcellular view option in IPA, with nuclear localization is at
the bottom and extracellular/secreted proteins are at the top; cytoplasmic and plasma membrane proteins are located as indicated.
Transcript icons and color scheme are IPA defaults. Brieﬂy, red, orange and yellow are up-regulated, blue and green are down-regulated, and gray are unknown/no prediction as either actual or predicted depending on molecule. Overlays and predictions (provided by
the Molecule Activity Predictor function in IPA) were done using transcript expression values for the respective comparison analysis.

36 h hCG and 0 h hCG (Figure 1(A)). IPA was also used to
identify networks showing changes between treatment
with 36 h hCG + celecoxib treatment and 36 h hCG
only (Figure 1(B)). For each comparison, the total list of
diﬀerentially-regulated genes (Table 2) as well as IPA predicted upstream regulators (Table 3) were connected to
generate the networks. In addition, colors indicating the
direction of change in mRNA expression were overlaid
for each panel in Figure 1. IPA’s Molecule Activation Predictor function colorizes network connections as blue or
orange when gene expression changes are consistent
with known gene relationships, and yellow when the

relationship is inconsistent. In both panels, numerous
blue and orange connections highlight the importance
of cell cycle regulation and pro-inﬂammatory responses
within these networks.

Granulosa cell proliferation is controlled by
gonadotropin and prostaglandins
Many of the upstream regulators predicted by pathway
analysis of our array data (Table 3) are associated with
cell cycle regulation. Importantly, three of these predicted upstream regulators (e.g. E2F2, RBL1, CCND1)

Table 3. Upstream regulators predicted to be signiﬁcantly regulated with hCG treatment (36 h hCG/0 h hCG) or with celecoxib
treatment (36 h hCG+celecoxib/36 h hCG) based on experimental data.
36 h hCG/0 h hCG
Molecule Type
Growth Factor
Kinases
Transcription Regulators
MicroRNA
Enzymes
Cytokines
Other

Activated
TGFB1, AGT
ATM
CDKN2A, NUPR1, SMARCB1, HSF1, RB1,
PPRC1, CEBPB, TP53, EZH2, RBL1, ERG
let-7
NDUFA13
TNF, CSF2, WNT5A, OSM, IL1A, IL1B
PGR, SHH, A2M

36 h hCG+celecoxib/36 h hCG
Inhibited

Activated

Inhibited

E2F2, CCND1,E2F4
miR-17-5p

TGFB2, INHBA
MAP2K1, MAP3K1
SMAD3, SMARCA4, ERG, RBL1,
KDM5A, RUVBL1
let-7

S100A6, EIF4G1

WNT5A
CD24, IGF1R, IGFBP2

IL5
CCND1, MYCN, MYC, FOXM1,
NCOA3, E2F2, E2F1
IL21
S100A6, SFTPA1, PCM1

Italics indicates regulators which diﬀer in both groups, but note that the direction of regulator activity change diﬀers in all cases, meaning that celecoxib counters
the directional regulation by hCG.
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Figure 2. E2F2 is a predicted node for regulation of granulosa cell cycle modulators. Panel A. Comparison of 36 h hCG-treated vs
untreated granulosa cells (36 h / 0 h) showed IPA predicted down-regulation (green) as the primary eﬀect of the predicted inhibition
(blue) of E2F2. Panel B. Comparison of 36 h hCG + celecoxib versus 36 h hCG in vivo (36 h + celecoxib/36 h) showed IPA predicted predominantly up-regulation (red) as the eﬀect of the predicted activation (orange) of E2F2 in granulosa cells.

are implicated in control of cell cycle progression
(Johnson and Walker 1999). Therefore, cell cycle regulation was selected for further analysis.
A network of E2F2-regulated genes was overlaid with
ratios of mRNA expression data from 36 h hCG/0 h hCG
and 36 h hCG + celecoxib/36 h hCG (Figure 2). These
comparisons were selected because they are physiologically meaningful. The ratio of 36 h hCG/0 h hCG reﬂects
changes stimulated by hCG as the follicle transitions
from a dominant preovulatory follicle to a luteinizing follicle just before ovulation (Figure 2(A)). Treatment with
hCG decreases expression of many cell cycle regulators,
as denoted by the green color. Importantly, the majority
of these proteins increase the rate of cell proliferation. In
addition, hCG increased expression of CDKN1A, an
inhibitor of cell cycle progression. It is important to
note that the overall impact of hCG is to subtly, but
not signiﬁcantly, alter the mRNA expression of many
cell cycle regulators, with the net eﬀect of decreasing
cell proliferation.
In contrast, the ratio of 36 h hCG + celecoxib/36 h hCG
shows the impact of prostaglandin depletion in the ovulatory follicle (Figure 2(B)). The overlay shows that prostaglandin depletion eﬀectively reverses the eﬀect of hCG,
upwardly shifting expression of many gene products
which increase cell proliferation and downwardly shifting expression expression of a cell cycle inhibitor,
CDKN1A. These data demonstrate that the role of hCGstimulated prostaglandins is to subtly shift cell cycle to
decrease the rate of cell proliferation. However, no
single mRNA is signiﬁcantly increased or decreased by
prostaglandins.
E2F2 is the predicted locus of control for this pathway
(Figure 2). IPA predicted that an ovulatory dose of hCG

decreases E2F2 activity as a control point for shifting
granulosa cells from a highly proliferative state to a
state of very limited cell cycle progression. Furthermore,
this analysis predicted that prostaglandins (stimulated by
hCG) subtly alter mRNA expression of this same cluster of
gene products to decrease cell cycle progression by via
the activity of E2F2.
Experiments conﬁrmed that mRNA levels for two cell
cycle regulators, CCNB1 and CCNE1, decreased after
exposure to hCG in vivo (Figure 3(A,B)). Treatment with
36 h hCG + celecoxib did not alter CCNB1 and CCNE1
levels when compared to treatment with 36 h hCG only
(Figure 3(A,B)). These ﬁndings are consistent with gene
expression levels in Figure 2. In this Figure, inhibition of
cell cycle regulation was seen in the 36 h hCG/0 h hCG
ratio and activation of cell cycle regulation was seen in
the 36 h hCG + celecoxib/36 h hCG ratio, albeit subtle.
Additional prospective studies were conducted to test
the hypothesis that prostaglandins mediate hCG-regulated reduction in cell cycle progression by follicular
granulosa cells. Ki67 immunodetection was performed
to determine the percentage of monkey granulosa cells
engaged in cell cycle progression before hCG treatment
(0 h hCG), at speciﬁc times after hCG administration, and
after treatment with 36 h hCG + celecoxib in vivo (Figure
3(C–F)). Before hCG administration, 45 ± 5% of granulosa
cells were Ki67 + . The percentage of Ki67+ granulosa
cells was signiﬁcantly reduced 24 h after hCG administration (31 ± 4%), and only 11 ± 3% of granulosa cells
were Ki67+ by 36 h after hCG administration. Co-administration of hCG and celecoxib yielded 39 ± 6% of granulosa cells determined to be Ki67+, similar to the
percentage of Ki67+ granulosa cells observed at 0 h
hCG. To determine if the speciﬁc prostaglandin PGE2 is
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Figure 3. hCG and PGE2 regulate granulosa cell proliferation. Panels A-B. CCNB1 (A) and CCNE1 (B) levels in monkey granulosa cells
obtained after ovarian stimulation without (0 h) hCG or 12, 24, or 36 h after administration of hCG; additional monkeys received
hCG and celecoxib for 36 h (36+C). mRNA of interest was expressed relative to ACTB. Panel C. The percentage of Ki67 immunopositive
granulosa cells in monkey ovarian tissues obtained after treatments described for Panels A-B. For each panel A-C, groups with no
common superscripts are diﬀerent by ANOVA and Duncans post hoc test, p<0.05; n=3–5 monkeys/time or treatment. Panels D-F. Representative images of Ki67 immunodetection in monkey granulosa cells (lower portion of each image) obtained after treatment with 0 h
hCG (D), 36 h hCG (E), and 36 h hCG + celecoxib (F). Example Ki67+ (arrow) and Ki67- (arrowhead) nuclei are indicated in Panel D; inset
in panel F shows lack of stain in granulosa cells when primary antibody was omitted. Panels G-H. Human granulosa cells received indomethacin alone (control) or in combination with hCG, PGE2, or hCG + PGE2 for 24 h (G) or 48 h (H) before Ki67 immunodetection; n = 4
women/treatment. For each panel G-H, groups with no common superscripts are diﬀerent by ANOVA with one repeated measure (for
repeated use of each woman’s cells) and Duncans post hoc test, p < 0.05. Panels I-L. Representative images of Ki67 immunodetection in
human granulosa cells cultured for 48 h with control media (I), hCG (J), PGE2 (K), or hCG + PGE2 (L). Example Ki67+ (arrow) and Ki67(arrowhead) nuclei are indicated in panel I. Inset in panel J shows lack of stain in granulosa cells when primary antibody was omitted.
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The overall goal of the present study was to utilize array
technology and pathway analysis to identify gene products and gene networks utilized by PGE2 to mediate
ovulation and luteinization. Previous studies showed
that PGE2 levels in primate follicles are elevated during
the second half of the interval between the ovulatory
gonadotropin surge and ovulation (Duﬀy and Stouﬀer
2001). The present analysis included identiﬁcation of
gene products which were diﬀerent before and 36 h
after hCG administration, just before the expected time
of ovulation. Co-administration of hCG and the PTGS2
inhibitor celecoxib was previously shown to prevent
rising intrafollicular prostaglandins in monkeys (Seachord et al. 2005). If hCG-stimulated prostaglandins are
important regulators of a gene product within the follicle, then it was anticipated that hCG would increase
and hCG + celecoxib would decrease expression levels.
The converse (expression decreased by hCG and
expression increased by hCG + celecoxib) would also
indicate a role for prostaglandins to mediate hCG-regulated gene expression.
HIST1H2BL was signiﬁcantly decreased with hCG, but
increased HIST1H2BL with hCG + celecoxib did not
meet the signiﬁcance criteria established for this
study. A previous gene array study identiﬁed
HIST1H2BL as a hCG-regulated gene in granulosa
cells of human ovulatory follicles (Wissing et al.
2014). As a core histone protein, HIST1H2BL facilitates
DNA replication and cell proliferation (Marzluﬀ and
Duronio 2002). Decreased HIST1H2BL expression after
hCG exposure would contribute to decreased cell
cycle progression. Subtle, elevated expression with
hCG + celecoxib is consistent with a role for prostaglandins as key local mediators of a cluster of genes
which, acting together, contribute to granulosa cell
exit from cell cycle. However, a subtle change in the
expression of a single gene is unlikely to be

Discussion

involved in cessation of cell cycle progression, human
granulosa cells were maintained for 7 days in vitro
using culture conditions which restore responsiveness
to gonadotropin stimulation. Granulosa cells were
treated in vitro with the general cyclooxygenase inhibitor indomethacin to block endogenous prostaglandin
production; PGE2 was replaced in some cultures in the
absence or presence of hCG. Culture for 24 h did not
reveal diﬀerences in Ki67 immunodetection between
treatments (Figure 3(G)). However, cultures treated in
vitro for 48 h in vitro showed that PGE2, but not hCG,
reduced the percentage of Ki67 immunopositive cells
(Figure 3(H–L)).
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responsible for the major, prostaglandin-dependent
changes observed during ovulation in vivo.
Network analysis predicted that cell cycle regulation is
a major hCG- and prostaglandin-controlled process in
granulosa cells of ovulatory follicles. Celecoxib treatment
was predicted to alter expression and/or activity of the
cell cycle regulators E2F2, RBL1, and CCND1 in a
manner consistent with the hypothesis that hCG
decreases cell cycle progression in a prostaglandindependent manner. The RBL1 protein is thought to
bind to E2F2 and other members of the E2F family of
transcription regulators to decrease transcription of cell
cycle regulators and other gene products involved in
cell cycle progression (Johnson and Walker 1999). This
includes regulation of CCND1 (also known as cyclin
D1), which regulates the transition from the G1 to S
phase of the cell cycle (Johnson and Walker 1999). The
concept that the transcription regulator E2F2 serves as
a control point for cell cycle regulation speciﬁcally in
granulosa cells is supported by the linkage of E2F2 to
expression of many cell cycle regulators, also shown to
be modestly up- or down-regulated in monkey granulosa
cells. This ﬁnding is complementary to a recent report of
network analysis in human granulosa cells without and
with hCG, where all networks with predicted decreases
in activity with hCG were related to cell cycle (Wissing
et al. 2014). Indeed, this analysis of human granulosa
cells included many of the speciﬁc gene products identiﬁed in the present study. It is interesting to note that
many genes predicted to be regulated by E2F2 were
altered in a direction consistent with hCG + prostaglandin-reduced cell cycle activity, even though the modest
change in the expression level of each of these genes
did not meet the stringent signiﬁcance criteria for
changes in mRNA levels set for this study. However,
these ﬁnding are consistent with the hypothesis that
prostaglandin stimulation leads to small changes in
levels of mRNA, protein, and/or activity of many cell
cycle regulators, and combined contributions of these
many small changes cause an overall decreased the
rate of cell cycle progression.
The prediction that a prostaglandin, and in particular
PGE2, is involved in granulosa cell withdrawal from cell
cycle was tested directly in vivo and in vitro. Administration of hCG in vivo caused a decrease in the percentage of granulosa cells in active cell cycle, as
determined by immunodetection of Ki67. These data
are consistent with previous reports showing that granulosa cells exit cell cycle in the hours following the ovulatory gonadotropin surge (Robker and Richards 1998;
Chaﬃn et al. 2001). In contrast, co-administration of
hCG and celecoxib for 36 h failed to cause granulosa
cell exit from cell cycle. This ﬁnding indicates that a
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PTGS2 product is necessary for hCG to reduce proliferation in granulosa cells. Our in vitro studies of human
granulosa cells identiﬁed PGE2 as the key prostaglandin
involved in cell cycle regulation. Previous reports ﬁnd
limited evidence of a correlation between prostaglandins
and granulosa cell proliferation (Wang et al. 1992; Li J et al.
1996; Mori et al. 2011; Li F et al. 2012), but there was no
consensus as to whether prostaglandins promote or
inhibit cell cycle progression. Some studies demonstrate
that granulosa cell exit from cell cycle begins before prostaglandins accumulate in the follicle (Mikuni et al. 1998;
Duﬀy and Stouﬀer 2001), indicating that the ovulatory
gonadotropin surge is likely the initial stimulus for granulosa cell cycle exit. However, the present study shows that
a PTGS2 product is needed for cell cycle exit in vivo, and
PGE2 is able to stimulate primate granulosa cell exit from
cell cycle in vitro. While gonadotropin likely initiates cell
cycle exit in vivo, gonadotropin-stimulated production of
PGE2 is needed to achieve and maintain very low rates
of granulosa cell proliferation which occur at the time of
ovulation and luteal formation.
Cessation of proliferation is a prerequisite for diﬀerentiation from the follicular granulosa cell phenotype to the
luteal cell phenotype (reviewed in (Robker and Richards
1998)). Functional luteinization, as deﬁned by elevated
progesterone production, is initiated by gonadotropin,
independent of prostaglandins, in non-human primates
and women (Duﬀy 2015). Structural luteinization
includes granulosa cell hypertrophy to become large
luteal cells, formation of a capillary network within the
granulosa cells, and replacement of the antral space
with a mature corpus luteum; these changes do not
occur when prostaglandin synthesis is inhibited during
exposure to an ovulatory dose of gonadotropin (Kim
et al. 2014; Trau et al. 2015). A critical role for follicular
prostaglandins in granulosa cell cycle exit is consistent
with the formation of luteinized unruptured follicles. In
women with endogenous LH surges or receiving hCG
to initiate ovulatory events, co-administration of a prostaglandin synthesis inhibitor caused the formation of
luteinized unruptured follicles (Killick and Elstein 1987;
Pall et al. 2001; Jesam et al. 2010). These follicles continue
to increase in diameter after the LH surge or hCG and can
remain as ﬂuid-ﬁlled, cystic structures for a week or more
after an ovulatory dose of gonadotropin. Similar studies
in non-human primates and cows used intrafollicular
administration of a prostaglandin synthesis inhibitor to
prevent elevated follicular prostaglandins after administration of a ovulatory dose of hCG. These treatments
resulted in formation of enlarged, cystic structures with
multiple layers of unluteinized, proliferative granulosa
cells (Peters et al. 2004; Kim et al. 2014). Normal or
near-normal serum progesterone levels measured in
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these studies support the concept that functional luteinization occurs in the absence of prostaglandins. Elevated
intrafollicular prostaglandins are involved in structural
luteinization and contribute to this process, at least in
part, by stimulating granulosa cell exit from cell cycle.
The study presented here used non-human primate
granulosa cell RNA obtained after speciﬁc conditions of
hCG administration and prostaglandin depletion to facilitate identiﬁcation of a previously-unappreciated network
of prostaglandin-sensitive granulosa cell gene products.
However, this approach did not identify many granulosa
cell mRNAs previously shown to be hCG-regulated in
human and non-human primate ovarian cells (Xu et al.
2011; Wissing et al. 2014; Yerushalmi et al. 2014).
Oocytes and surrounding cumulus were manually
removed from our follicular aspirates, so the cells used
for gene array analysis in the present study were
thought to be primarily (but not exclusively) mural granulosa cells. Prostaglandin-regulated gene products implicated in cumulus expansion in rodents (reviewed in
(Russell and Robker 2007)) were likely not identiﬁed in
the present study since many cumulus cells were
removed prior to preparation of cDNA for analysis.
Expression levels for many mural granulosa cell gene
products increase immediately after the LH surge or
hCG administration and are low again by the time of ovulation in primates (Chaﬃn et al. 1999, 2000; Duﬀy, Dozier,
et al. 2005). mRNAs regulated in this fashion would not
be detected by our analysis. Focused analysis of changing patterns of gene expression late in the ovulatory
interval allowed identiﬁcation of cell cycle regulation as
a PGE2-sensitive process that is essential for both ovulation and formation of a fully-functional corpus luteum.
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